Photo by visuals from unsplash
rucaparib. This switch resulted in a key approach to prevent new relapses, allowing the continuation of PARP inhibitors. Dermatologists and oncologists need to be aware of the existence of skin… Click to show full abstract
rucaparib. This switch resulted in a key approach to prevent new relapses, allowing the continuation of PARP inhibitors. Dermatologists and oncologists need to be aware of the existence of skin toxicities due to PARP inhibitors and of the possibility of switching PARP inhibitors as an effective approach to prevent the therapeutic discontinuation and therefore maintain the benefits of these targeted therapies.
Keywords:
centrifugum following;
erythema annulare;
following sars;
parp inhibitors;
annulare centrifugum;
sars cov
Journal Title: International Journal of Dermatology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: International Journal of Dermatology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!